These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32146705)

  • 21. [Proarrhythmic effects of domperidone in infants: a systematic review].
    Caraballo L; Molina G; Weitz D; Piskulic L; Avila A; Marzi M
    Farm Hosp; 2014 Sep; 38(5):438-44. PubMed ID: 25344138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.
    Rojas-Fernandez C; Stephenson AL; Fischer HD; Wang X; Mestre T; Hutson JR; Pondal M; Lee DS; Rochon PA; Marras C
    Drugs Aging; 2014 Nov; 31(11):805-13. PubMed ID: 25227452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of domperidone on QT interval in neonates.
    Djeddi D; Kongolo G; Lefaix C; Mounard J; Léké A
    J Pediatr; 2008 Nov; 153(5):663-6. PubMed ID: 18589449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T
    Can J Gastroenterol Hepatol; 2016; 2016():2937678. PubMed ID: 27446835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
    Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
    Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?
    Lertxundi U; Domingo-Echaburu S; Soraluce A; García M; Ruiz-Osante B; Aguirre C
    Curr Drug Saf; 2013 Feb; 8(1):63-8. PubMed ID: 23656449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.
    Drolet B; Rousseau G; Daleau P; Cardinal R; Turgeon J
    Circulation; 2000 Oct; 102(16):1883-5. PubMed ID: 11034933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
    Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
    J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis.
    Mehrabadi A; Reynier P; Platt RW; Filion KB
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1316-1324. PubMed ID: 30106193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domperidone: ventricular arrhythmia and sudden death (continued).
    Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone.
    Yüksel K; Tuğlular I
    Int J Clin Pharm; 2019 Apr; 41(2):387-390. PubMed ID: 30864085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
    Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
    PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisapride and ventricular arrhythmia.
    Hennessy S; Leonard CE; Newcomb C; Kimmel SE; Bilker WB
    Br J Clin Pharmacol; 2008 Sep; 66(3):375-85. PubMed ID: 18662288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Safety of Metoclopramide Compared to Domperidone: A Population-Based Cohort Study.
    Cowan A; Garg AX; McArthur E; Muanda Tsobo F; Weir MA
    J Can Assoc Gastroenterol; 2021 Oct; 4(5):e110-e119. PubMed ID: 34617008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database.
    Hennessy S; Leonard CE; Palumbo CM; Bilker WB; Newcomb C; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1131-6. PubMed ID: 18613261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording.
    Berger F; Saâïd S; van Gelder T; Stricker B; Becker M; van den Bemt P
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1418-1424. PubMed ID: 28924989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.
    Simeonova M; de Vries F; Pouwels S; Driessen JHM; Leufkens HGM; Cadarette SM; Burden AM
    Br J Clin Pharmacol; 2018 Nov; 84(11):2551-2561. PubMed ID: 29975795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.